These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 10389030)

  • 1. Vitamin E and other antioxidants in neuroprotection.
    Behl C
    Int J Vitam Nutr Res; 1999 May; 69(3):213-9. PubMed ID: 10389030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection].
    Behl C; Holsboer F
    Fortschr Neurol Psychiatr; 1998 Mar; 66(3):113-21. PubMed ID: 9565761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative nerve cell death in Alzheimer's disease and stroke: antioxidants as neuroprotective compounds.
    Behl C; Moosmann B
    Biol Chem; 2002; 383(3-4):521-36. PubMed ID: 12033440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach.
    Behl C; Moosmann B
    Free Radic Biol Med; 2002 Jul; 33(2):182-91. PubMed ID: 12106814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
    Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
    Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin E protects neurons against oxidative cell death in vitro more effectively than 17-beta estradiol and induces the activity of the transcription factor NF-kappaB.
    Behl C
    J Neural Transm (Vienna); 2000; 107(4):393-407. PubMed ID: 11215751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antioxidant vitamin E modulates amyloid beta-peptide-induced creatine kinase activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer's disease.
    Yatin SM; Aksenov M; Butterfield DA
    Neurochem Res; 1999 Mar; 24(3):427-35. PubMed ID: 10215518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease.
    Sung S; Yao Y; Uryu K; Yang H; Lee VM; Trojanowski JQ; Praticò D
    FASEB J; 2004 Feb; 18(2):323-5. PubMed ID: 14656990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin E as an antioxidant/free radical scavenger against amyloid beta-peptide-induced oxidative stress in neocortical synaptosomal membranes and hippocampal neurons in culture: insights into Alzheimer's disease.
    Butterfield DA; Koppal T; Subramaniam R; Yatin S
    Rev Neurosci; 1999; 10(2):141-9. PubMed ID: 10658956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches.
    Behl C
    Prog Neurobiol; 1999 Feb; 57(3):301-23. PubMed ID: 10096843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin E in neurodegenerative disorders: Alzheimer's disease.
    Kontush K; Schekatolina S
    Ann N Y Acad Sci; 2004 Dec; 1031():249-62. PubMed ID: 15753151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin E and other endogenous antioxidants in the central nervous system.
    Vatassery GT
    Geriatrics; 1998 Sep; 53 Suppl 1():S25-7. PubMed ID: 9745632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of vitamin E on the oxidative stress in Hansen's disease (Leprosy) patients.
    Vijayaraghavan R; Suribabu CS; Sekar B; Oommen PK; Kavithalakshmi SN; Madhusudhanan N; Panneerselvam C
    Eur J Clin Nutr; 2005 Oct; 59(10):1121-8. PubMed ID: 16015260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Vitamin E in the Treatment of Alzheimer's Disease: Evidence from Animal Models.
    Gugliandolo A; Bramanti P; Mazzon E
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferulic acid ethyl ester protects neurons against amyloid beta- peptide(1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity.
    Sultana R; Ravagna A; Mohmmad-Abdul H; Calabrese V; Butterfield DA
    J Neurochem; 2005 Feb; 92(4):749-58. PubMed ID: 15686476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidants, oxidative stress, and degenerative neurological disorders.
    Floyd RA
    Proc Soc Exp Biol Med; 1999 Dec; 222(3):236-45. PubMed ID: 10601882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metals, oxidative stress and neurodegenerative disorders.
    Jomova K; Vondrakova D; Lawson M; Valko M
    Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease.
    Calabrese V; Butterfield DA; Stella AM
    Ital J Biochem; 2003 Dec; 52(4):177-81. PubMed ID: 15141484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity.
    Varadarajan S; Yatin S; Aksenova M; Butterfield DA
    J Struct Biol; 2000 Jun; 130(2-3):184-208. PubMed ID: 10940225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons.
    Melo JB; Sousa C; Garção P; Oliveira CR; Agostinho P
    Eur J Neurosci; 2009 Feb; 29(3):455-64. PubMed ID: 19222556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.